- Home
- NEGG vs CDXS Comparison
NEGG vs CDXS Comparison
Compare NEGG & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- CDXS
- Stock Information
- Founded
- NEGG 2001
- CDXS 2002
- Country
- NEGG United States
- CDXS United States
- Employees
- NEGG N/A
- CDXS N/A
- Industry
- NEGG Other Specialty Stores
- CDXS Major Chemicals
- Sector
- NEGG Consumer Discretionary
- CDXS Industrials
- Exchange
- NEGG Nasdaq
- CDXS Nasdaq
- Market Cap
- NEGG 293.6M
- CDXS 332.0M
- IPO Year
- NEGG 2010
- CDXS 2010
- Fundamental
- Price
- NEGG $0.63
- CDXS $3.88
- Analyst Decision
- NEGG
- CDXS Buy
- Analyst Count
- NEGG 0
- CDXS 2
- Target Price
- NEGG N/A
- CDXS $11.00
- AVG Volume (30 Days)
- NEGG 558.6K
- CDXS 654.0K
- Earning Date
- NEGG 11-22-2024
- CDXS 10-31-2024
- Dividend Yield
- NEGG N/A
- CDXS N/A
- EPS Growth
- NEGG N/A
- CDXS N/A
- EPS
- NEGG N/A
- CDXS N/A
- Revenue
- NEGG $1,391,833,000.00
- CDXS $64,446,000.00
- Revenue This Year
- NEGG $6.01
- CDXS N/A
- Revenue Next Year
- NEGG N/A
- CDXS $2.02
- P/E Ratio
- NEGG N/A
- CDXS N/A
- Revenue Growth
- NEGG N/A
- CDXS N/A
- 52 Week Low
- NEGG $0.58
- CDXS $1.85
- 52 Week High
- NEGG $2.15
- CDXS $4.91
- Technical
- Relative Strength Index (RSI)
- NEGG 44.36
- CDXS 59.70
- Support Level
- NEGG $0.62
- CDXS $3.95
- Resistance Level
- NEGG $0.68
- CDXS $4.20
- Average True Range (ATR)
- NEGG 0.06
- CDXS 0.24
- MACD
- NEGG 0.00
- CDXS 0.02
- Stochastic Oscillator
- NEGG 21.23
- CDXS 61.07
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.